IRFA-MUM1 Genetic Test: Comprehensive FISH Analysis for Oncology
Understanding the IRFA-MUM1 Genetic Test
The IRFA-MUM1 genetic test represents a cutting-edge molecular diagnostic approach in oncology, utilizing Fluorescence In Situ Hybridization (FISH) technology to detect specific genetic alterations in tumor tissue. This specialized test plays a crucial role in modern cancer diagnostics, providing physicians with essential genetic information that can significantly impact treatment planning and patient outcomes.
What Does the IRFA-MUM1 Test Measure?
The IRFA-MUM1 test specifically targets and analyzes:
- MUM1 gene rearrangements and translocations
- Genetic abnormalities in paraffin-embedded tumor tissue samples
- Specific chromosomal alterations associated with hematological malignancies
- Molecular markers that influence treatment response and prognosis
Who Should Consider the IRFA-MUM1 Test?
Clinical Indications and Symptoms
This test is particularly valuable for patients experiencing:
- Unexplained lymph node enlargement or swelling
- Suspected hematological malignancies or lymphomas
- Abnormal blood cell counts or bone marrow findings
- Patients with diagnosed cancers requiring genetic characterization
- Individuals with family history of hematological cancers
- Patients needing treatment guidance based on genetic markers
Key Benefits of IRFA-MUM1 Genetic Testing
Undergoing the IRFA-MUM1 test provides numerous advantages:
- Precision Diagnosis: Accurate identification of specific genetic abnormalities
- Treatment Guidance: Helps determine the most effective therapeutic approaches
- Prognostic Information: Provides insights into disease progression and outcomes
- Personalized Medicine: Enables tailored treatment strategies based on genetic profile
- Comprehensive Analysis: Utilizes advanced FISH technology for reliable results
- Quick Turnaround: Results available within 7-8 days
Understanding Your Test Results
Interpreting IRFA-MUM1 Findings
Your test results will provide detailed information about:
- Presence or absence of MUM1 gene rearrangements
- Specific genetic abnormalities detected
- Clinical significance of identified genetic markers
- Potential implications for treatment selection
- Prognostic indicators based on genetic findings
Important Note: All results should be discussed with your healthcare provider who can provide personalized interpretation based on your complete medical history and clinical presentation.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $226 |
| Regular Price | $300 |
Nationwide Availability
GGC DNA has testing facilities across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures convenient access to advanced genetic testing services.
Pre-Test Instructions and Requirements
The IRFA-MUM1 test requires:
- Sample Type: Tumor tissue (paraffin-embedded tissue blocks)
- Prescription: Doctor’s prescription required (except for surgery, pregnancy, or travel abroad cases)
- Turnaround Time: 7-8 days from sample receipt
- Methodology: FISH (Fluorescence In Situ Hybridization)
Take Control of Your Health Today
Don’t wait to get the genetic insights you need for informed healthcare decisions. Our experienced team is ready to assist you with scheduling your IRFA-MUM1 genetic test and answering any questions you may have about the testing process.
Call or WhatsApp us today at +1(267) 388-9828 to book your test or speak with our genetic counseling team.
At GGC DNA, we’re committed to providing accurate, reliable genetic testing that empowers patients and healthcare providers with the information needed to make the best possible medical decisions. Trust our expertise in oncology genetics to guide your healthcare journey.
